Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

Rogue Funds, LLC 2024 Q4 Investor Letter | Buyside Digest

Back to Fund Profile (Rogue Funds, LLC)

Primary Source Intelligence • Q4 2024 Letter Analysis

Rogue Funds, LLC Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, Rogue Funds, LLC. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

QTD+8.59%

Digest Analysis

Quick Take

"Portfolio finally settled into core positions after extensive 2024 turnover. Largest holding ASP Isotopes benefits from nuclear growth and unique isotope production."

Executive Summary

Rogue Funds delivered 8.59% net returns in Q4 2024, bringing since-inception returns to 71.0% versus 41.6% for the S&P 500. The fund operates a highly concentrated portfolio of small-cap positions with significant volatility expected to continue. Portfolio turnover has finally settled after extensive repositioning throughout 2024, with the manager now comfortable holding core positions for the foreseeable future. Key holdings include ASP Isotopes as the largest position, benefiting from nuclear industry growth and unique isotope production capabilities, ElectroCore in medical devices approaching profitability, Achieve Life Sciences in biotechnology with breakthrough drug designation, and private investment Green Data Centers building infrastructure for hyperscalers. The manager sold several positions including HAYPP Group, Aware, RADCOM, and Mitchell Services primarily for tax harvesting and opportunity cost reasons. Looking ahead, numerous immediate catalysts over the next 12-18 months could drive significant valuation changes across core positions, with three new positions being added to the portfolio.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

82%

CautiousHigh

High Conviction (82%)

Extremely high conviction evidenced by concentrated portfolio with ASP Isotopes as largest position that manager visited personally and plans to hold indefinitely. Specific position sizing mentioned (ElectroCore 10%+ position) and detailed thesis explanations for each holding. Manager explicitly states extreme confidence and comfort with current holdings despite acknowledging volatility.

Growth Outlook

25%

BearishBullish

Bearish (25%)

Manager shows selective optimism about specific opportunities like Argentina's turnaround and data center capex continuing, but expresses significant concerns about real estate markets, European stagnation, and Japanese rate risks. Overall cautiously positive but acknowledging meaningful headwinds.

Risk Appetite

60%

DefensiveAggressive

Balanced (60%)

Fund is highly concentrated with ASP Isotopes as largest position and expects to maintain this concentration. Manager explicitly states comfort with current holdings and plans to hold for foreseeable future. Adding three new core positions indicates continued risk-on positioning despite acknowledging volatility.

Capital Deployment

35%

De-riskingDeploying

Net Neutral (35%)

Manager is adding three new core positions and recently bought more Achieve Life Sciences, indicating moderate deployment activity. However, also sold multiple positions (HAYPP, Aware, RADCOM, Mitchell Services) primarily for tax harvesting. Net effect appears to be selective rotation and modest new deployment rather than aggressive cash deployment.

Forward Guidance

40%

CautiousExpansionary

Neutral (40%)

Manager is actively building three new core positions and expects to hold most current positions for foreseeable future. However, also acknowledges potential delays and headwinds in some holdings like ElectroCore warrant dilution. Selective deployment bias with focus on existing conviction positions.

Language Signal

30%

BearishBullish

Bearish (30%)

Language contains significant opportunity-focused terms around ASP Isotopes, data centers, and biotechnology catalysts, but also substantial risk language around real estate markets, European stagnation, Japanese rates, and various company-specific concerns. Roughly balanced with slight positive tilt.

Perceived Risk

72%

Low RiskElevated

Elevated Risk (72%)

Manager identifies multiple significant macro risks including commercial real estate disarray, Japanese rate shock potential, US real estate stagnation, and European regulatory/policy concerns. Also acknowledges company-specific execution risks and warrant dilution issues. Substantial discussion of various risk factors throughout the letter.

Opportunity Density

65%

ScarceAbundant

Abundant (65%)

Manager sees selective opportunities in specific areas like nuclear/isotopes, biotechnology, and data centers, and is adding three new core positions. However, explicitly avoiding entire regions (Europe, China, Japan) and sectors (real estate) due to poor conditions. Characterizes environment as requiring selectivity rather than broad opportunity abundance.

Time Horizon

75%

Short-TermLong-Term

Decade+ (75%)

Manager explicitly states plans to hold most positions for the foreseeable future and mentions 3-5 year internal hurdle rate expectations. However, also focuses on immediate catalysts over next 12-18 months and 6-month profitability timelines for some holdings. Multi-year thesis with some near-term catalyst dependency.